Pharma

Your Article Summary

See Latest Articles

DeCODE Announces Transfer of the Listing of its Common Stock from Nasdaq Global Market to Nasdaq Capital Market
deCODE genetics, 05/15/09

DeCODE genetics announced that on February 2009, it received a letter from the Nasdaq Listing Qualifications Panel stating that the Panel will transfer the listing of deCODE’s common stock from the Nasdaq Global Market to the Nasdaq Capital Market, effective at the open of the trading session on Wednesday, February 2009. The Nasdaq Capital Market, which is one of the three market tier designations for Nasdaq-listed stock, is a continuous trading market that operates in substantially the same manner as the Nasdaq Global Market. It includes the securities of approximately 550 companies. deCODE's trading symbol will remain DCGN and trading of its common stock will be unaffected by the transfer.

Today in Marketing/Media/ROI...keeping you current

Receive free subspecialty "5-minute updates" via email

Personalized Medicine Market To Grow 11% Annually
PharmExec, 12/16/09

Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09

Alcon to Enter Surgical Glaucoma Market by Acquiring Optonol
Alcon, 12/15/09

 See all of Marketing/Media/ROI